Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EDGEWELL PERSONAL CARE CoEPC · Entity 4787 | Director | February 05, 2026 | February 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EDGEWELL PERSONAL CARE Co
Report date February 05, 2026 · Filed February 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Equivalents 2-5-2026SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,817 |
Reported balance
After 2026-02-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-05 · Grant · Acquired 7,817 · Balance 7,817 F1: Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KMG CHEMICALS INC
Report date November 15, 2018 · Filed November 15, 2018
Section 16 reporting ended · disclosed 2018-11-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-15 transaction · row 1
1 source rowRow 1 · 2018-11-15 · Disposition to issuer · Disposed 19,331 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 14, 2018, by and among KMG Chemicals, Inc. ("KMG"), Cabot Microelectronics Corporation ("Cabot Microelectronics") and Cobalt Merger Sub Corporation, in exchange for 3,866 shares of Cabot Microelectronics common stock and $1,075,791 in cash consideration at the Effective Time of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 14, 2018, by and among KMG Chemicals, Inc. ("KMG"), Cabot Microelectronics Corporation ("Cabot Microelectronics") and Cobalt Merger Sub Corporation, in exchange for 3,866 shares of Cabot Microelectronics common stock and $1,075,791 in cash consideration at the Effective Time of the merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2026 Filed Feb 9, 2026 15:47 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents 2-5-2026 · Derivative | 7,817 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001181630-26-000002 · form4-02092026_030238.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,817 Underlying: Common Stock · 7,817 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 14:49 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents 2-6-2025 · Derivative | 4,999 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004534 · wk-form4_1739198946.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,999 Underlying: Common Stock · 4,999 shares Expires not disclosed F1 · derivative.expiration_date: Restricted stock equivalents convert into sharers of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 18:35 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 2-1-2024 · Derivative | 3,853 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-003226 · wk-form4_1707158119.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,853 Underlying: Common Stock · 3,853 shares Expires not disclosed F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 13:40 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/03/2023 · Derivative | 3,318 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007406 · doc4.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,318 Underlying: Common Stock · 3,318 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 21:23 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/04/2022 · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007446 · doc4.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 3,375 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| February 04, 2021 Filed Feb 8, 2021 16:42 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/04/2021 · Derivative | 3,799 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008420 · doc4.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,799 Underlying: Common Stock · 3,799 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 14:44 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/06/2020 · Derivative | 3,944 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007778 · doc4.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,944 Underlying: Common Stock · 3,944 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 20:46 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/01/2019 · Derivative | 3,156 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007278 · doc4.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,156 Underlying: Common Stock · 3,156 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| November 15, 2018 Filed Nov 15, 2018 15:03 UTC | KMG CHEMICALS INC KMG · Entity 162390 | Disposition to issuerCommon Stock | 19,331 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-012876 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 14, 2018, by and among KMG Chemicals, Inc. ("KMG"), Cabot Microelectronics Corporation ("Cabot Microelectronics") and Cobalt Merger Sub Corporation, in exchange for 3,866 shares of Cabot Microelectronics common stock and $1,075,791 in cash consideration at the Effective Time of the merger. Read SEC document |
| November 07, 2018 Filed Nov 13, 2018 18:03 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GiftCommon Stock | 500 | $76.47 | $38,235.00 |
DisclosureSEC source: 0001179110-18-012790 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,331 F1 · shares: Charitable gift. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 14:29 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCommon Stock | 266 | $75.02 | $19,955.32 |
DisclosureSEC source: 0001179110-18-012480 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,742 Read SEC document |
| November 01, 2018 Filed Nov 8, 2018 21:28 UTC Amendment | KMG CHEMICALS INC KMG · Entity 162390 | Exercise / conversionCommon Stock | 89 | $75.02 | $6,676.78 |
DisclosureSEC source: 0001179110-18-012701 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: To correct the transaction code from A to M, and to reflect that 89 additional shares were issued. F1 · shares: To correct the transaction code from A to M, and to reflect that 89 additional shares were issued. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 16:10 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCOMMON STOCK | 261 | $71.80 | $18,739.80 |
DisclosureSEC source: 0001179110-18-010135 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,476 Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 18:24 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionRestricted Stock Equivalent 07/08/2015 · Derivative | 2,002 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042281 · doc4.xml · derivative · entry 2 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,002 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/9/2018. F1 · derivative.expiration_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/9/2018. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 18:24 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionCommon Stock | 2,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042281 · doc4.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2018 Filed May 3, 2018 14:53 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCOMMON STOCK | 305 | $61.49 | $18,754.45 |
DisclosureSEC source: 0001179110-18-006134 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,215 Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 14:38 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 552 | $54.50 | $30,084.00 |
DisclosureSEC source: 0001209191-18-011793 · doc4.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,601 Read SEC document |
| February 01, 2018 Filed Feb 1, 2018 17:22 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCOMMON STOCK | 309 | $60.75 | $18,771.75 |
DisclosureSEC source: 0001179110-18-001341 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,910 Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:43 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 1/2/2018 · Derivative | 2,072 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-000947 · doc4.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,072 Underlying: Common Stock · 2,072 shares Expires not disclosed F1 · derivative.exercise_date: Annual Restricted Stock Equivalent award valued at $125,000 will vest one year from date of grant unless Reporting Person elects to defer conversion. F1 · derivative.expiration_date: Annual Restricted Stock Equivalent award valued at $125,000 will vest one year from date of grant unless Reporting Person elects to defer conversion. Read SEC document |
| November 01, 2017 Filed Nov 3, 2017 11:28 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCOMMON STOCK | 340 | $55.13 | $18,744.20 |
DisclosureSEC source: 0001179110-17-013688 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,601 Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 16:17 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCOMMON STOCK | 370 | $50.62 | $18,729.40 |
DisclosureSEC source: 0001179110-17-010967 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,261 Read SEC document |
| April 28, 2017 Filed May 4, 2017 18:04 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCommon Stock | 356 | $52.55 | $18,707.80 |
DisclosureSEC source: 0001179110-17-006589 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,891 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 16:22 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCommon Stock | 508 | $36.86 | $18,724.88 |
DisclosureSEC source: 0001179110-17-001483 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,535 Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 16:51 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 1/3/2017 · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001697 · doc4.xml · derivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,667 Underlying: Common Stock · 1,667 shares Expires not disclosed F1 · derivative.exercise_date: Annual Restricted Stock Equivalent award valued at $125,000 will vest one year from date of grant unless Reporting Person elects to defer conversion. F1 · derivative.expiration_date: Annual Restricted Stock Equivalent award valued at $125,000 will vest one year from date of grant unless Reporting Person elects to defer conversion. Read SEC document |
| October 31, 2016 Filed Oct 31, 2016 17:54 UTC | KMG CHEMICALS INC KMG · Entity 162390 | GrantCommon Stock | 691 | $27.14 | $18,753.74 |
DisclosureSEC source: 0001179110-16-031023 · edgar.xml · nonDerivative · entry 1 HUNTER JOHN C III · CIK 0001181630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,027 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.